Kamada (KMDA) Non-Current Deffered Revenue (2016 - 2021)

Kamada (KMDA) posted quarterly Non-Current Deffered Revenue of $15000.0 for Q4 2021, down 99.26% year-on-year from $2.0 million in Q4 2020, and down 99.26% on a QoQ basis from $2.0 million in Q4 2020.

Kamada (KMDA) Non-Current Deffered Revenue (2016 - 2021) Analysis & Trends

Kamada (KMDA) has reported Non-Current Deffered Revenue for 6 consecutive years, with $15000.0 the latest figure, recorded in Q4 2021.

  • Quarterly Non-Current Deffered Revenue fell 99.26% year-over-year to $15000.0 in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $15000.0 (down 99.26% YoY) and the FY2021 annual result came in at $15000.0, down 99.26% from the prior year.
  • Non-Current Deffered Revenue fell to $15000.0 in Q4 2021 per KMDA's latest filing, from $2.0 million in the prior quarter.
  • Over the last five years, Non-Current Deffered Revenue for KMDA reached as high as $2.0 million in Q4 2020 and fell as low as $15000.0 in Q4 2021.
  • A 5-year average of $729400.0 and a median of $668000.0 in 2018 frame the typical range for Non-Current Deffered Revenue.
  • Annual changes were most pronounced in 2020 — Non-Current Deffered Revenue surged 772.84% — and 2021, when it sank 99.26%.
  • Year by year, Non-Current Deffered Revenue stood at $707000.0 in 2017, then slipped by 5.52% to $668000.0 in 2018, then slumped by 65.27% to $232000.0 in 2019, then jumped by 772.84% to $2.0 million in 2020, then plunged by 99.26% to $15000.0 in 2021.
  • According to Business Quant data, Non-Current Deffered Revenue over the past three periods registered $15000.0, $2.0 million, and $232000.0 for Q4 2021, Q4 2020, and Q4 2019 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 Kamada 401.22 Mn 328.07 Mn 19.12 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2021 15,000.00
Dec 31, 2020 2.03 Mn
Dec 31, 2019 232,000.00
Dec 31, 2018 668,000.00
Dec 31, 2017 707,000.00
Dec 31, 2016 3.66 Mn